157 related articles for article (PubMed ID: 37834111)
1. BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma Cells.
Zhang Q; Chen X; Hu Y; Zhou T; Du M; Xu R; Chen Y; Tang P; Chen Z; Li J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834111
[TBL] [Abstract][Full Text] [Related]
2. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
Cao Y; Zhu W; Chen W; Wu J; Hou G; Li Y
Dis Markers; 2019; 2019():5451290. PubMed ID: 31093306
[TBL] [Abstract][Full Text] [Related]
4. LINC00511 Knockdown Suppresses Resistance to Cisplatin in Lung Adenocarcinoma by Interacting with miR-182-3p and BIRC5.
Zhu Z; Shi Y; Gong X; Li J; Zhang M
Mol Biotechnol; 2022 Mar; 64(3):252-262. PubMed ID: 34595724
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
Li H; Tong L; Tao H; Liu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
[TBL] [Abstract][Full Text] [Related]
7. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma.
Chen C; Liu H; Li Y; Xu Q; Liu J
BMC Cancer; 2024 Jan; 24(1):63. PubMed ID: 38216925
[TBL] [Abstract][Full Text] [Related]
9. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
Song Y; Tang W; Li H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
[TBL] [Abstract][Full Text] [Related]
10. α5-nAChR and survivin: Two potential biological targets in lung adenocarcinoma.
Zhang Y; Sun Y; Jia Y; Zhang Q; Zhu P; Ma X
J Cell Physiol; 2021 Mar; 236(3):1787-1797. PubMed ID: 33196129
[TBL] [Abstract][Full Text] [Related]
11. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
12. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes in the tumor microenvironment of lung adenocarcinoma.
Long W; Li Q; Zhang J; Xie H
Med Oncol; 2021 Jun; 38(7):83. PubMed ID: 34117948
[TBL] [Abstract][Full Text] [Related]
15. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
Dong S; Men W; Yang S; Xu S
Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
[TBL] [Abstract][Full Text] [Related]
16. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
18. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
19. BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma.
Wang N; Huang X; Cheng J
PeerJ; 2022; 10():e12871. PubMed ID: 35178302
[TBL] [Abstract][Full Text] [Related]
20. MS-275 potentiates the effect of YM-155 in lung adenocarcinoma via survivin downregulation induced by miR-138 and miR-195.
Luo BL; Zhou Y; Lv H; Sun SH; Tang WX
Thorac Cancer; 2019 Jun; 10(6):1355-1368. PubMed ID: 31090206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]